BioXcel Therapeutics (BTAI) Restructuring Costs (2023 - 2025)

BioXcel Therapeutics' Restructuring Costs history runs 3 years deep, the most recent figure standing at $194000.0 for Q3 2025.

• In Q3 2025, Restructuring Costs fell 87.51% year-over-year to $194000.0; the TTM figure through Dec 2025 stood at $227000.0 (down 90.7% YoY), while the FY2025 annual figure was $194000.0, down 92.05% from the prior year.
• Restructuring Costs was $194000.0 for Q3 2025 at BioXcel Therapeutics, up from $33000.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $4.2 million in Q3 2023 to a low of $33000.0 in Q4 2024.
• Historically, Restructuring Costs has averaged $1.4 million across 3 years, with a median of $856000.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Restructuring Costs slumped 62.7% in 2024, then tumbled 87.51% in 2025.
• A 3-year view of Restructuring Costs shows it stood at $4.2 million in 2023, then plunged by 99.21% to $33000.0 in 2024, then surged by 487.88% to $194000.0 in 2025.
• The last three Restructuring Costs figures came in at $194000.0 (Q3 2025), $33000.0 (Q4 2024), and $1.6 million (Q3 2024), per Business Quant data.